Scilex Holding (SCLX) Revenue (2022 - 2026)
Scilex Holding (SCLX) posted quarterly Revenue of $8.6 million for Q1 2026, up 72.0% year-over-year from $5.0 million in Q1 2025, and up 77.69% quarter-over-quarter from $4.8 million in Q4 2025.
Scilex Holding (SCLX) Revenue (2022 - 2026) Analysis & Trends
Scilex Holding's Revenue history runs 5 years deep, the most recent figure standing at $8.6 million for Q1 2026.
- In Q1 2026, Revenue rose 72.0% year-over-year to $8.6 million; the TTM figure through Mar 2026 stood at $33.9 million (down 33.17% YoY), while the FY2025 annual figure was $30.3 million, down 46.47% from the prior year.
- Revenue for Q1 2026 stood at $8.6 million, up from $4.8 million in the prior quarter.
- The five-year high for Revenue was $16.4 million in Q2 2024, with the low at $4.8 million in Q4 2025.
- The 5-year median for Revenue is $10.6 million (2023), against an average of $10.6 million.
- The sharpest annual moves came in 2025 and 2026: Revenue plunged 67.54% in 2025, then soared 72.0% in 2026.
- Scilex Holding's Revenue stood at $11.9 million in 2022, then rose by 12.95% to $13.5 million in 2023, then increased by 10.76% to $14.9 million in 2024, then slumped by 67.54% to $4.8 million in 2025, then soared by 77.69% to $8.6 million in 2026.
- Business Quant data shows SCLX's Revenue at $8.6 million in Q1 2026, $4.8 million in Q4 2025, and $10.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.50 Bn | 631.74 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 469.68 Bn | 463.11 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 375.54 Bn | 368.40 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 303.20 Bn | 295.51 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.76 Bn | 252.86 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 236.70 Bn | 222.71 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 182.32 Bn | 179.14 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 159.56 Bn | 147.86 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Gsk | 106.15 Bn | 101.98 Bn | 8.24 Bn | 11.28 Bn |
| 10 | Scilex Holding | 39.10 Mn | -73.69 Mn | 3.97 Mn | 7.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.60 Mn |
| Dec 31, 2025 | 4.84 Mn |
| Sep 30, 2025 | 10.56 Mn |
| Jun 30, 2025 | 9.90 Mn |
| Mar 31, 2025 | 5.00 Mn |
| Dec 31, 2024 | 14.91 Mn |
| Sep 30, 2024 | 14.44 Mn |
| Jun 30, 2024 | 16.37 Mn |
| Mar 31, 2024 | 10.88 Mn |
| Dec 31, 2023 | 13.46 Mn |
| Sep 30, 2023 | 10.12 Mn |
| Jun 30, 2023 | 12.58 Mn |
| Mar 31, 2023 | 10.58 Mn |
| Dec 31, 2022 | 11.92 Mn |
| Sep 30, 2022 | 11.38 Mn |
| Jun 30, 2022 | 7.93 Mn |
| Mar 31, 2022 | 6.81 Mn |